Zac Bissonnette of BloggingStocks.com notes that a recent Bloomberg News story about a biosolar company uses a research report that the company paid the analyst to produce.
The company may earn $6.3 million this year on initial sales of its backsheets, Victor Sula, an analyst at Beacon Equity Research in Frisco, Texas, said.
“‘Because of silicon supply constraints, companies developing technologies for replacing silicon in solar cell manufacturing are trading at premium valuation multiples,’ Sula wrote. He rates BioSolar a ‘speculative buy’ with a target price of $1.37.
“What Bloomberg doesn’t mention — but should — is this little disclosure that sits at the bottom of Sula’s report on the company:
“‘Beacon Equity Research and its affiliates have been directly compensated a total of fifteen thousand dollars and one hundred thousand restricted rule 144 shs directly from the company for enrollment of BSRC in this research program and other marketing services.’
“In a recent post, I discussed the troubling track record of Beacon Equity Research’s stock picks, and Kevin Kelly pointed out serious red flags at BioSolar. We have contacted the reporter for a response and will include it if we get one.
“It’s a shame that a reputable news organization like Bloomberg is playing a role in pumping BioSolar and hopefully the newsroom’s editors will take a hard look at the quality of the reporting on the piece. In the meantime investors should, as always, proceed with caution.”
Read more here. The story can be read here. The stock closed up more than 20 percent on Friday.
Morgan Meaker, a senior writer for Wired covering Europe, is leaving the publication after three…
Nick Dunn, who is currently head of CNBC Events as senior vice president and managing…
Wall Street Journal editor in chief Emma Tucker sent out the following on Friday: Dear…
New York Times metro editor Nestor Ramos sent out the following on Friday: We are delighted to…
Rahat Kapur of Campaign looks at the evolution The Wall Street Journal. Kapur writes, "The transformation…
This position will be Hybrid in the office/market 3 days per week, and those days…
View Comments
wow. Can someone PLEASE bring a recorder into the room when Winkler hears about this one.
"THE ERROR WAS THE HUMAN. NOW LET'S GO FIND THAT HUMAN AND SQUISH THAT HUMAN LIKE THE BUG HE/SHE IS"
Someone should check and see how many shares/call options the bowtied-maniac bought of BioSolar before this article ran. of course, we know what his mouth-foaming, vein-popping response would be: I DIDN'T PLACE THE ORDER. MY COMPUTER DID. IT WAS A COMPUTER ERROR!!!!!!!!!!!!!!!!!!!!!